MDT

97.97

-0.41%↓

VEEV

301.82

-1.22%↓

A

141.04

+1.79%↑

HQY

92.06

+4.03%↑

PHR.US

23.23

-0.43%↓

MDT

97.97

-0.41%↓

VEEV

301.82

-1.22%↓

A

141.04

+1.79%↑

HQY

92.06

+4.03%↑

PHR.US

23.23

-0.43%↓

MDT

97.97

-0.41%↓

VEEV

301.82

-1.22%↓

A

141.04

+1.79%↑

HQY

92.06

+4.03%↑

PHR.US

23.23

-0.43%↓

MDT

97.97

-0.41%↓

VEEV

301.82

-1.22%↓

A

141.04

+1.79%↑

HQY

92.06

+4.03%↑

PHR.US

23.23

-0.43%↓

MDT

97.97

-0.41%↓

VEEV

301.82

-1.22%↓

A

141.04

+1.79%↑

HQY

92.06

+4.03%↑

PHR.US

23.23

-0.43%↓

Search

Thermo Fisher Scientific Inc

Chiusa

SettoreSettore sanitario

536.41 -0.58

Panoramica

Variazione del prezzo dell'azione

24h

Corrente

Minimo

533.7

Massimo

548.59

Metriche Chiave

By Trading Economics

Entrata

100M

1.6B

Vendite

491M

11B

P/E

Media del settore

26.878

35.739

Rendimento da dividendi

0.35

Margine di Profitto

14.878

Dipendenti

125,000

EBITDA

1.1B

2.8B

Raccomandazioni

By TipRanks

Raccomandazioni

Fortemente da comprare

Previsioni per 12 mesi

+2.41% upside

Dividendi

By Dow Jones

Rendimento da dividendi

Media del settore

0.35%

3.08%

Utili prossimi

22 ott 2025

Prossima data del Dividendo

15 ott 2025

Prossima data del' Ex Dividendo

12 dic 2025

Statistiche di mercato

By TradingEconomics

Capitalizzazione di Mercato

22B

175B

Apertura precedente

536.99

Chiusura precedente

536.41

Notizie sul Sentiment di mercato

By Acuity

28%

72%

90 / 371 Classifica in Healthcare

Punteggio Tecnico

By Trading Central

Fiducia

Bearish Evidence

Thermo Fisher Scientific Inc Grafico

Le prestazioni passate non sono un indicatore affidabile dei risultati futuri.

Notizie correlate

23 lug 2025, 10:33 UTC

Utili

Thermo Fisher Scientific 2Q Profit, Revenue Rise

25 giu 2025, 21:19 UTC

Acquisizioni, Fusioni, Takeovers

Solventum Removes Drinking-Water Unit From Thermo Fisher's Planned Filtration Buy

28 mag 2025, 14:02 UTC

Acquisizioni, Fusioni, Takeovers

Brookfield, Caisse de Depot Buy Antylia Scientific From GTCR for $1.34 Billion

23 apr 2025, 10:33 UTC

Utili

Thermo Fisher 1Q Net, Revenue Up, Costs Stable

25 feb 2025, 14:05 UTC

Acquisizioni, Fusioni, Takeovers

Thermo Fisher Scientific to Acquire Solventum's Filtration Unit, Confirming WSJ Report

2 set 2025, 12:15 UTC

Acquisizioni, Fusioni, Takeovers

Thermo Fisher Scientific Completes Acquisition Of Sanofi's Ridgefield, New Jersey Site >TMO

2 set 2025, 12:08 UTC

Acquisizioni, Fusioni, Takeovers

Solventum Had Seen 2025 Adjusted EPS $5.80-$5.95 >SOLV

2 set 2025, 12:08 UTC

Acquisizioni, Fusioni, Takeovers

Solventum Raises 2025 View To Adj EPS $5.88-Adj EPS $6.03 >SOLV

2 set 2025, 12:04 UTC

Acquisizioni, Fusioni, Takeovers

Solventum to Use Net Proceeds Primarily to Pay Down Debt >SOLV

2 set 2025, 12:03 UTC

Acquisizioni, Fusioni, Takeovers

Solventum Closes Sale of Unit to Thermo Fisher for $4 Billion in Cash >SOLV

2 set 2025, 12:03 UTC

Acquisizioni, Fusioni, Takeovers

Thermo Fisher Completes Acquisition of Purification & Filtration Business of Solventum for About $4B in Cash >TMO

2 set 2025, 12:00 UTC

Acquisizioni, Fusioni, Takeovers

Solventum Completes Sale of Purification & Filtration Business to Thermo Fisher Scientific >SOLV TMO

23 lug 2025, 10:00 UTC

Utili

Thermo Fisher 2Q Organic Revenue Rose 2% >TMO

23 lug 2025, 10:00 UTC

Utili

Thermo Fisher 2Q Adj EPS $5.36 >TMO

23 lug 2025, 10:00 UTC

Utili

Thermo Fisher 2Q Net $1.62B >TMO

23 lug 2025, 10:00 UTC

Utili

Thermo Fisher 2Q EPS $4.28 >TMO

23 lug 2025, 10:00 UTC

Utili

Thermo Fisher 2Q Rev $10.85B >TMO

14 lug 2025, 16:12 UTC

Discorsi di Mercato
Acquisizioni, Fusioni, Takeovers

Waters Closer to Thermo Fisher, Danaher With Becton Dickinson Unit -- Market Talk

14 lug 2025, 15:06 UTC

Acquisizioni, Fusioni, Takeovers

Waters Stock Is Falling on Deal to Combine With Becton Dickinson Unit -- Barrons.com

28 mag 2025, 13:47 UTC

Acquisizioni, Fusioni, Takeovers

Brookfield, Caisse de Depot Buy Antylia Scientific From GTCR for $1.34B

23 apr 2025, 10:01 UTC

Utili

Thermo Fisher 1Q Adjusted Operating Margin 21.9% >TMO

23 apr 2025, 10:00 UTC

Utili

Thermo Fisher 1Q Organic Revenue Rose 1% >TMO

23 apr 2025, 10:00 UTC

Utili

Thermo Fisher 1Q EPS $3.98 >TMO

23 apr 2025, 10:00 UTC

Utili

Thermo Fisher 1Q Rev $10.36B >TMO

23 apr 2025, 10:00 UTC

Utili

Thermo Fisher 1Q Adj EPS $5.15 >TMO

23 apr 2025, 10:00 UTC

Utili

Thermo Fisher 1Q Net $1.51B >TMO

25 feb 2025, 14:09 UTC

Acquisizioni, Fusioni, Takeovers

Thermo Fisher Strikes Deal for Solventum's Filtration Unit -- WSJ

25 feb 2025, 13:41 UTC

Acquisizioni, Fusioni, Takeovers

Solventum: Transaction Is Expected to Be Completed by End of 2025 >SOLV

25 feb 2025, 13:40 UTC

Acquisizioni, Fusioni, Takeovers

Solventum Expects Estimated $3.4 B in Net Proceeds >SOLV

25 feb 2025, 13:40 UTC

Acquisizioni, Fusioni, Takeovers

Solventum: Deal Strengthens Balance Sheet With Proceeds to Be Used Primarily for Debt Paydown >SOLV

Confronto tra pari

Modifica del prezzo

Thermo Fisher Scientific Inc Previsione

Obiettivo di Prezzo

By TipRanks

2.41% in crescita

Previsioni per 12 mesi

Media 552.17 USD  2.41%

Alto 590 USD

Basso 500 USD

Basato su 20 analisti di Wall Street che offrono Obiettivi di Prezzo a 12 mesi per Thermo Fisher Scientific Inc - Dist negli ultimi 3 mesi.

Consenso sulla valutazione

By TipRanks

Fortemente da comprare

20 ratings

16

Acquista

4

Mantieni

0

Vendi

Punteggio Tecnico

By Trading Central

406.5 / 417.79Supporto e resistenza

A breve termine

Bearish Evidence

A termine intermedio

Bearish Evidence

A lungo termine

Strong Bearish Evidence

Sentiment

By Acuity

90 / 371 Classifica in Settore sanitario

Notizie sul Sentiment di mercato

Prove rialziste

Volatilità

Sotto la media

Volume delle notizie (RCV)

Sopra la media

Notizie finanziarie

Spese di vendita e di amministrazione

Spese operative

Utile prima delle imposte

Vendite

Costo delle vendite

Utile lordo sulle vendite

Interessi passivi sul debito

EBITDA

Utile operativo

$

Chi Siamo Thermo Fisher Scientific Inc

Thermo Fisher Scientific Inc. provides life sciences solutions, analytical instruments, specialty diagnostics, and laboratory products and biopharma services in the North America, Europe, Asia-Pacific, and internationally. The company's Life Sciences Solutions segment offers reagents, instruments, and consumables for biological and medical research, discovery, and production of drugs and vaccines, as well as diagnosis of infections and diseases; and solutions include biosciences, genetic sciences, and bio production to pharmaceutical, biotechnology, agricultural, clinical, healthcare, academic, and government markets. Its Analytical Instruments segment provides instruments, consumables, software, and services for pharmaceutical, biotechnology, academic, government, environmental, and other research and industrial markets, as well as clinical laboratories. The company's Specialty Diagnostics segment offers liquid, ready-to-use, and lyophilized immunodiagnostic reagent kits, as well as calibrators, controls, protein detection assays, and instruments; immunodiagnostics develops, manufactures and markets complete bloodtest systems to support the clinical diagnosis and monitoring of allergy, asthma and autoimmune diseases; dehydrated and prepared culture media, collection and transport systems, instrumentation, and consumables; human leukocyte antigen typing and testing for organ transplant market; and healthcare products. Its Laboratory Products and Biopharma Services segment provides laboratory products, research and safety market channel, and pharma services and clinical research. It offers products and services through a direct sales force, customer-service professionals, electronic commerce, and third-party distributors under Thermo Scientific; Applied Biosystems; Invitrogen; Fisher Scientific; Unity Lab Services; and Patheon and PPD. It has a collaboration agreement with Mainz Biomed N.V. for the development of colorectal cancer screening product. Thermo Fisher Scientific Inc. was founded in 1956 and is headquar
help-icon Live chat